title: Methotrexate renal clearance by low-dose dopamine in severe nephrotoxicity.
authors.affiliation: a Nephrology, Dialysis, Transplantation , Fondazione I.R.C.C.S. Policlinico San Matteo , Pavia , Italy.
authors.forename: Fabrizio
authors.initials: F
authors.lastname: Grosjean
authors.affiliation: a Nephrology, Dialysis, Transplantation , Fondazione I.R.C.C.S. Policlinico San Matteo , Pavia , Italy.
authors.forename: Vincenzo
authors.initials: V
authors.lastname: Sepe
authors.affiliation: b Hematology , Fondazione I.R.C.C.S. Policlinico San Matteo , Pavia , Italy.
authors.forename: Manuel
authors.initials: M
authors.lastname: Gotti
authors.affiliation: b Hematology , Fondazione I.R.C.C.S. Policlinico San Matteo , Pavia , Italy.
authors.forename: Marianna
authors.initials: M
authors.lastname: Rossi
authors.affiliation: a Nephrology, Dialysis, Transplantation , Fondazione I.R.C.C.S. Policlinico San Matteo , Pavia , Italy.|c Chair of Nephrology , University of Pavia , Italy.
authors.forename: Antonio
authors.initials: A
authors.lastname: Dal Canton
mesh_terms: D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D004298:Dopamine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007677:Kidney Function Tests; D008297:Male; D008727:Methotrexate / Q000009:adverse effects*; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000964:Antimetabolites, Antineoplastic; D014665:Vasodilator Agents; D004298:Dopamine; D008727:Methotrexate